Filing Flows › Core Scientific, Inc./tx (CORZ) › Q2 2025
Core Scientific, Inc./tx (CORZ) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 8, 2025
Core Scientific, Inc./tx (CORZ) reported revenue of $78.6M for the second quarter 2025 (Q2 2025), -44% from a year earlier and -1% from the quarter before. Operating margin was -33.4%.
Core Scientific, Inc./tx, Q2 2025: revenue $78.6M (-44% year over year), operating margin -33.4%, net loss $937M, operating cash flow $34.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $78.6M | -1% | -44% |
| Operating profit | −$26.3M | — | — |
| Net earnings | −$937M | -263% | — |
| Operating cash flow | $34.0M | — | 28× |
What changed
Revenue was $78.6M in Q2 2025, down 44% year over year and down 1% from the previous quarter.
Gross margin was 6.4%, down 21.1 points from a year earlier. Operating costs exceeded revenue by $26.3M, an operating margin of -33.4%. Operating expenses fell 76% while revenue fell 44%. The quarter ended with a net loss of $936.8M, after a profit of $576.3M the previous quarter. Net interest and other expense of $910.4M was the main reason.
Operating cash flow was $34.0M (up 2724% year over year). Non-cash charges added back $18.8M of depreciation and amortization and $24.2M of share-based compensation. Working capital and other items added $927.9M. Capital expenditures of $121.3M exceeded it, leaving free cash flow of −$87.3M.
Questions
What was Core Scientific, Inc./tx's revenue in the second quarter 2025?
Core Scientific, Inc./tx (CORZ) reported revenue of $78.6M for the second quarter 2025 (Q2 2025), -44% from a year earlier and -1% from the quarter before.
Was Core Scientific, Inc./tx profitable in the second quarter 2025?
Operating loss was $26.3M (-33.4% of revenue) and net loss $937M.